Innoviva, Inc. financial data

Symbol
INVA on Nasdaq
Industry
Pharmaceutical Preparations
Location
1350 Old Bayshore Highway, Suite 400, Burlingame, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
THERAVANCE INC (to 12/7/2015), ADVANCED MEDICINE INC (to 8/2/2000)
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 996 % +147%
Quick Ratio 117 % +97.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62.6M shares -3.9%
Common Stock, Shares, Outstanding 62.6M shares -4.08%
Entity Public Float 924M USD +9.88%
Common Stock, Value, Issued 626K USD -4.14%
Weighted Average Number of Shares Outstanding, Basic 62.5M shares -4.31%
Weighted Average Number of Shares Outstanding, Diluted 62.5M shares -4.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 330M USD +13.8%
Research and Development Expense 12.8M USD -74.1%
General and Administrative Expense 24.2M USD +28%
Costs and Expenses 177M USD +716%
Operating Income (Loss) 359M USD +4.09%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 153M USD -43.1%
Income Tax Expense (Benefit) 7.57M USD -89.4%
Earnings Per Share, Basic 2.25 USD/shares -33%
Earnings Per Share, Diluted 1.67 USD/shares -34.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 217M USD +25.4%
Inventory, Net 36.7M USD -21.7%
Other Assets, Current 2.15M USD +0.47%
Assets, Current 358M USD +10.7%
Deferred Income Tax Assets, Net 11.4M USD +80.9%
Property, Plant and Equipment, Net 427K USD +165%
Operating Lease, Right-of-Use Asset 3.12M USD +14.7%
Intangible Assets, Net (Excluding Goodwill) 217M USD -10.6%
Goodwill 17.9M USD +20.3%
Other Assets, Noncurrent 2.98M USD -16.3%
Assets 1.22B USD +9.54%
Accounts Payable, Current 2.04M USD -55.6%
Employee-related Liabilities, Current 4.76M USD -13.1%
Liabilities, Current 28.2M USD -28.4%
Deferred Income Tax Liabilities, Net 0 USD
Operating Lease, Liability, Noncurrent 1.98M USD +6.73%
Other Liabilities, Noncurrent 72.1M USD +5.08%
Retained Earnings (Accumulated Deficit) -23.3M USD +86.2%
Stockholders' Equity Attributable to Parent 566M USD +36.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 666M USD +19.9%
Liabilities and Equity 1.22B USD +9.54%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 37M USD +44.2%
Net Cash Provided by (Used in) Financing Activities -9.17M USD +93.3%
Net Cash Provided by (Used in) Investing Activities -43M USD -20.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 62.6M shares -4.08%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.2M USD +89.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 217M USD +25.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.18M USD -16.5%
Deferred Tax Assets, Valuation Allowance 169M USD +16.9%
Deferred Tax Assets, Gross 228M USD +12.4%
Operating Lease, Liability 3.43M USD +11.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 180M USD -16%
Lessee, Operating Lease, Liability, to be Paid 3.8M USD +12.5%
Operating Lease, Liability, Current 1.45M USD +18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 435K USD -66.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.71M USD +33.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -11.9%
Deferred Income Tax Expense (Benefit) 3.24M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 361K USD +24.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 455K USD
Deferred Tax Assets, Operating Loss Carryforwards 182M USD +21.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 230K shares 0%
Unrecognized Tax Benefits 19.4M USD +19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 325K USD
Operating Lease, Payments 320K USD -17.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 25.9M USD +80.6%
Depreciation, Depletion and Amortization 3.5M USD +1.19%
Deferred Tax Assets, Net of Valuation Allowance 58.7M USD +1.11%
Share-based Payment Arrangement, Expense 5.82M USD -28.7%
Interest Expense 22M USD +22.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%